Sales and Marketing

Showing 15 posts of 11527 posts found.

Merck KGaA’s rising revenues fail to lift bottom line

October 27, 2009 Sales and Marketing Merck Serono

 Revenues up, earnings down: that was the bottom line to Merck KGaA’s financial performance in the three months to the …

European regulators begin Tysabri review

October 26, 2009 Sales and Marketing EU, Tysabri, reg

European regulators have begun a risk-benefit review of Biogen Idec’s multiple sclerosis drug Tysabri, which has been linked to 23 …

Anna ‘Lito’ Michala, sales executive, TRB Chemedica UK

October 23, 2009 Sales and Marketing TRB Chemedica, appoinment, appointment, sales and marketing

TRB Chemedica UK has appointed Anna ‘Lito’ Michala as sales executive for Scotland and the North of England.Lito joins the …

European approval for 3-in-1 version of Exforge

October 23, 2009 Sales and Marketing Diovan, Exforge, Novartis, cv, hypertension

European regulators have approved an expanded version of Novartis’ high blood pressure treatment Exforge.Exforge was first approved in Europe in …

Januvia helps stabilise Merck sales

October 23, 2009 Sales and Marketing Januvia, Merck

 Merck has turned in stable figures for the third quarter of the year, with global sales up 2% on the …

Cost-cutting helps Pfizer’s bottom line

October 22, 2009 Sales and Marketing Pfizer

Pfizer's third-quarter results have seen it reap the benefit of its cost-cutting measures, including a reduction in headcount of around …

EFPIA starts anti-counterfeiting pilots in Sweden

October 21, 2009 Manufacturing and Production, Sales and Marketing EU, counterfeits, supply chain

More than 100,000 products and 25 retail pharmacies in Stockholm will take part in a two-month anti-counterfeiting project run by …

Barbara Britten, business developement director, Pharmexx UK

October 21, 2009 Sales and Marketing appointment, pharmexx, sales and marketing

Barbara Britten has joined Pharmexx UK as a business developement director.She most recently worked at Actelion, where she held the …

UK begins swine flu vaccinations with GSK jab

October 21, 2009 Sales and Marketing h1n1, hc

The UK's swine flu vaccination programme began today with NHS hospitals offering the jabs to frontline healthcare workers and patients …

GSK kidney cancer drug approved in US

October 20, 2009 Research and Development, Sales and Marketing Cancer, GSK, rcc

 GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …

First details emerge of Pfizer site closures

October 20, 2009 Research and Development, Sales and Marketing MA, Pfizer, restructure

 The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …

GSK’s Cervarix finally wins US approval

October 19, 2009 Sales and Marketing Cervarix, GSK, US

US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …

AZ-BMS launch Onglyza in Europe

October 19, 2009 Sales and Marketing AZ, BMS, DPP-4, Onglyza, diabetes

 Bristol-Myers Squibb and AstraZeneca’s long-awaited type II diabetes drug Onglyza has been launched in the UK, its first European market.Designed …

Quality regulator slams NHS trusts

October 16, 2009 Sales and Marketing NHS, hc

The Care Quality Commission has slammed nearly 50 NHS trusts in its latest annual report on the care which patients …

Johnson & Johnson rides out patent attack

October 16, 2009 Sales and Marketing JJ, generics

 Profits at Johnson & Johnson have risen in the third quarter, despite deep cuts into pharma sales caused by new …
The Gateway to Local Adoption Series

Latest content